
Paras Healthcare IPO Listing: Shares Debut at 3.9% Premium on NSE and BSE, Check Share Price
Paras Healthcare lists at Rs 720 on NSE and BSE, up 3.9%. Issue price Rs 693. Subscribed about 2.34 times. Issue size Rs 1,450 Cr.
Updated: 28 Oct 2026 • 11:01 am
Posted by:

Quick Answer
The Paras Healthcare IPO listing today saw the stock debut at Rs 720 on both the NSE and BSE, a 3.9 percent premium over the Rs 693 issue price. Anyone checking the Paras Healthcare share price today will find a modest listing gain of Rs 27 per share for a North India hospital chain whose IPO was subscribed only about 2.34 times.
Paras Healthcare IPO Listing Today: The IPO closed subscription on 23 October 2026 at about 2.34 times overall. Here is a recap of the offer, the terms of the Paras Healthcare IPO listing, and how the stock traded once it opened on 28 October.
Click Here – Get Free Investment Predictions
Paras Healthcare IPO Listing: Issue Details
Paras Healthcare raised about Rs 1,450 crore through a book built issue of 2,09,23,520 shares in a price band of Rs 660 to Rs 693 per share. It was a mix of a Rs 500 crore fresh issue of 72,15,007 shares and a Rs 950 crore offer for sale of 1,37,08,513 shares. The shares listed on the NSE and BSE on 28 October 2026. Bidding ran from 21 to 23 October 2026.
| Particular | Detail |
|---|---|
| Allotment Date | 26 October 2026 |
| IPO Open Date | 21 October 2026 |
| IPO Close Date | 23 October 2026 |
| Refund Initiation | 27 October 2026 |
| Issue Size | About Rs 1,450 crore (Rs 500 crore fresh issue plus Rs 950 crore offer for sale) |
| Lot Size | 21 shares (minimum retail application Rs 14,553) |
| Price Band | Rs 660 to Rs 693 per share |
| Issue Type | Book Built Issue |
| Lead Managers | JM Financial, BofA Securities India and Nuvama Wealth Management |
| Registrar | MUFG Intime India Private Limited |
| Listing At | NSE and BSE |
| Listing Date | 28 October 2026 |
Check Live Stock Data on the Univest Screener
Paras Healthcare IPO Listing Price and Performance
Shares of the Paras Healthcare IPO listing opened at Rs 720 on both exchanges, a gain of Rs 27, or 3.9 percent, over the Rs 693 issue price. A retail investor applying for one lot of 21 shares had put in Rs 14,553, so the paper gain at the listing price works out to about Rs 567 per lot. For the smallest HNI application of 14 lots, or 294 shares, the gain is about Rs 7,938. The stock edged to Rs 723.10 shortly after opening, in line with the lukewarm subscription.
About the Paras Healthcare IPO
Paras Healthcare operates hospitals under the Paras Health brand and was founded in 1987. It runs eight hospitals with 2,211 beds across North India, Bihar and Jharkhand, with cardiac, oncology, neuro, gastro, orthopaedic and renal care making up about 75 percent of FY26 revenue. It plans a 300 bed hospital in Gurugram and a 500 bed hospital in Ludhiana. Dharminder Kumar Nagar is the promoter, and he and Commelina sold shares in the offer. JM Financial, BofA Securities India and Nuvama were the lead managers. Investors weighing the Paras Healthcare IPO listing should note that about Rs 376 crore of the fresh issue goes to repaying debt.
Download the Univest iOS App or Univest Android App to track Paras Healthcare live share price after the Paras Healthcare IPO listing and get daily stock recommendations.
Paras Healthcare Financials
Here is how the company has performed financially, useful context for anyone checking the Paras Healthcare share price today after the Paras Healthcare IPO listing.
| Year Ended | 31 Mar 2026 (Rs cr.) | 31 Mar 2025 (Rs cr.) | 31 Mar 2024 (Rs cr.) |
|---|---|---|---|
| Total Income | 1,628.78 | 1,314.21 | 1,151.02 |
| EBITDA | 335.58 | 156.46 | 154.41 |
| Profit After Tax | 43.83 | (57.98) | (15.33) |
| Total Borrowings | 1,393.86 | 1,232.12 | 923.92 |
Explanation
Total income rose about 24 percent in FY26 to Rs 1,628.78 crore and the company turned a profit of Rs 43.83 crore after losses of Rs 57.98 crore in FY25 and Rs 15.33 crore in FY24. Borrowings kept climbing to Rs 1,393.86 crore, and the issue priced the shares at about 38 times post issue earnings, so the modest gain after the Paras Healthcare IPO listing fits the risks.
Grey market premium (GMP) is an unofficial, unregulated indicator for the Paras Healthcare IPO that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data around the Paras Healthcare IPO listing can go through other relevant sources, though such figures should never be the sole basis for an investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs
What was the Paras Healthcare IPO listing price?
Ans. Paras Healthcare shares listed at Rs 720 on both the NSE and BSE, a 3.9 percent premium over the Rs 693 issue price.
Was the Paras Healthcare IPO listing a premium or a discount?
Ans. It was a modest premium listing, with the stock opening Rs 27 above the issue price.
How much was the Paras Healthcare IPO subscribed?
Ans. The IPO was subscribed about 2.34 times overall by the close of bidding on 23 October 2026, with the QIB portion at about 3.25 times and retail at about 2.10 times.
What is the issue price of the Paras Healthcare IPO?
Ans. The price band was Rs 660 to Rs 693 per share, and the issue price was fixed at the upper end, Rs 693.
What is the lot size of the Paras Healthcare IPO?
Ans. The lot size was 21 shares, and a retail investor needed Rs 14,553 for one lot at the upper end of the band.
Who is the registrar for the Paras Healthcare IPO?
Ans. MUFG Intime India Private Limited is the registrar.
What does Paras Healthcare do?
Ans. Paras Healthcare operates a chain of eight hospitals in North India, Bihar and Jharkhand under the Paras Health brand.
Where can I check the Paras Healthcare share price today?
Ans. You can check the Paras Healthcare share price today on the NSE and BSE platform, or through the Univest platform.
Should I hold shares after the Paras Healthcare IPO listing?
Ans. That depends on your own risk appetite and time horizon. Worth weighing the return to profit and bed expansion plans against high borrowings and a rich valuation before deciding whether to hold or book profit after the Paras Healthcare IPO listing.
Recent Articles

Ramky Infrastructure (RAMKY) Share Price Rises 10.71% to Rs 283.20 Today
28 October 2026

Hindustan Adhesives (HINDADH) Share Price Falls 8.35% to Rs 362 on 28 October 2026
28 October 2026

WEWORK INDIA MANAGEMENT L (WEWORK): WeWork India Share Price Rise: Stock Gains 5.06% Today
28 October 2026

FDC (FDC) Share Price Rise: Stock Gains 5.5% Today
28 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Ramky Infrastructure (RAMKY) Share Price Rises 10.71% to Rs 283.20 Today
Hindustan Adhesives (HINDADH) Share Price Falls 8.35% to Rs 362 on 28 October 2026
WEWORK INDIA MANAGEMENT L (WEWORK): WeWork India Share Price Rise: Stock Gains 5.06% Today
FDC (FDC) Share Price Rise: Stock Gains 5.5% Today
MTAR Technologies (MTARTECH) Share Price Rise: Stock Gains 2.88% Today
Popular this week
Tata Consultancy Services (TCS) Share Price Falls 3.14% Today: Price Action and Fundamentals

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





